JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB128175

Anti-IGF2BP2/IMP-2 antibody [1E3.01E5]

Be the first to review this product! Submit a review

|

(43 Publications)

Mouse Monoclonal IGF2BP2/IMP-2 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 43 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human IGF2BP2.

View Alternative Names

IMP2, VICKZ2, IGF2BP2, Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, IMP-2, Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, VICKZ family member 2

3 Images
Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)
  • WB

Supplier Data

Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)

All lanes:

Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (ab128175) at 1/1000 dilution

Lane 1:

Hep-G2 whole cell lysate at 50 µg

Lane 2:

HeLa whole cell lysate at 50 µg

Lane 3:

HEK293T whole cell lysate at 50 µg

Lane 4:

Jurkat whole cell lysate at 50 µg

Lane 5:

NIH 3T3 whole cell lysate at 50 µg

Secondary

All lanes:

Western blot - Goat Anti-Mouse IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-hrp-ab97023'>ab97023</a>)

Predicted band size: 66 kDa,70 kDa

Observed band size: 70 kDa,66 kDa

true

Exposure time: 10s

Immunoprecipitation - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)
  • IP

Supplier Data

Immunoprecipitation - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)

Lanes 1 + 2 : Whole cell lysate (1.0 mg per IP reaction; 20% of IP loaded) from HEK-293T cells prepared using NETN lysis buffer.

Lane 1 : ab128175
Lane 2 : Control IgG

ab128175 was used for IP at 20 μl/mg lysate. For blotting immunoprecipitated IGF2BP2, ab128175 was used at 1 : 1000. An HRP-conjugated goat anti-mouse IgG secondary antibody was used. Chemiluminescence with an exposure time of 3 seconds.

All lanes:

Immunoprecipitation - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (ab128175) at 1/1000 dilution

All lanes:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate

Predicted band size: 66 kDa

false

Exposure time: 3s

Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)
  • WB

Supplier Data

Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (AB128175)

Western blot analysis of whole cell lysates prepared using NETN lysis buffer labeling IGF2BP2/IMP-2 with ab128175 at a dilution of 1/1000. An HRP-conjugated goat anti-mouse IgG secondary was used. Chemiluminescence with an exposure time of 3 seconds.

All lanes:

Western blot - Anti-IGF2BP2/IMP-2 antibody [1E3.01E5] (ab128175) at 1/1000 dilution

Lane 1:

HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 50 µg

Lane 2:

HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg

Lane 3:

Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 50 µg

Lane 4:

TCMK-1 (Mouse kidney epithelial cell line) whole cell lysate at 50 µg

Lane 5:

NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 50 µg

Predicted band size: 66 kDa

false

Exposure time: 3s

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

1E3.01E5

Isotype

IgG1

Light chain type

kappa

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, IP

applications

Immunogen

Recombinant Full Length Protein corresponding to Human IGF2BP2.

Q9Y6M1

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "20 µl/mg of lysate", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" }, "Mouse": { "IP-species-checked": "guaranteed", "IP-species-dilution-info": "", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification notes
ab128175 was purified using a Mouse immunoglobulin binding ligand.
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.09% Sodium azide Constituents: 99% Tris buffered saline, 0.1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

RNA-binding factor that recruits target transcripts to cytoplasmic protein-RNA complexes (mRNPs). This transcript 'caging' into mRNPs allows mRNA transport and transient storage. It also modulates the rate and location at which target transcripts encounter the translational apparatus and shields them from endonuclease attacks or microRNA-mediated degradation (By similarity). Preferentially binds to N6-methyladenosine (m6A)-containing mRNAs and increases their stability (PubMed : 29476152). Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs (PubMed : 9891060). Binding is isoform-specific. Binds to beta-actin/ACTB and MYC transcripts. Increases MYC mRNA stability by binding to the coding region instability determinant (CRD) and binding is enhanced by m6A-modification of the CRD (PubMed : 29476152).
See full target information IGF2BP2

Publications (43)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 11:417 PubMed40883266

2025

METTL3-mediated m6A modification of circCDKAL1 regulates macrophage M1 polarization and nasal epithelial cell barrier function in allergic rhinitis through IGF2BP2/JARID2/HMGB1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Jiabin Zhan,Dan Luo,Yunlong Fu,Yu Zhou,Rui Li,Xin Wei

CNS neuroscience & therapeutics 31:e70463 PubMed40485217

2025

DeSUMOylation of IGF2BP2 Promotes Neuronal Differentiation of OM-MSCs by Stabilizing SOX11 to Ameliorate Brain Injury After Intracerebral Hemorrhage.

Applications

Unspecified application

Species

Unspecified reactive species

Jun He,Yuhan Luo,Chuang Wang,Chonghua Jiang,Jian Wang,Ying Xia

The Journal of biological chemistry 301:110303 PubMed40447192

2025

Post-transcriptional regulation of H19 by mA reader proteins: H19 stability versus miR-675 biogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Samarjit Jana,Abhishek Chowdhury,Kumaravel Somasundaram

Translational lung cancer research 14:1351-1370 PubMed40386722

2025

was stabilized through N-methyladenosine methylation and exerted its anticancer effects in lung squamous cell carcinoma by inhibiting SIRT1 activity via CCAR2.

Applications

Unspecified application

Species

Unspecified reactive species

Qihang Yan,Wingshing Wong,Jinsong Lei,Dachuan Liang,Jie Yang,Li Gong,Rossana Berardi,Shuqin Dai,Junye Wang

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 36:269-279 PubMed40241612

2025

Regulatory Role of IGF2BP2 in Intestinal Mucosal Barrier Dysfunction in Ulcerative Colitis.

Applications

Unspecified application

Species

Unspecified reactive species

Ruifan Li,Bin Gu,Anli Lv

Cancer cell international 25:122 PubMed40158101

2025

The m6A reader IGF2BP2 promotes pancreatic cancer progression through the m6A-SLC1A5-mTORC1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Pu,Yuting Wu,Weiguo Long,Xinyu Sun,Xiao Yuan,Deqiang Wang,Xu Wang,Min Xu

Journal of translational medicine 23:376 PubMed40148953

2025

Circ-ITCH promotes the ubiquitination degradation of HOXC10 to facilitate osteogenic differentiation in disuse osteoporosis through stabilizing BRCA1 mRNA via IGF2BP2-mediated mA modification.

Applications

Unspecified application

Species

Unspecified reactive species

Da Zhong,Xi Li,Zhen Yin,Peng Chen,Yusheng Li,Jian Tian,Long Wang,Hua Liu,Ke Yin,Lemei Zhu,Lingyu Kong,Kunli Chen,Yaochun Li,Chungu Hong,Chenggong Wang

World journal of diabetes 16:101328 PubMed40093288

2025

SMAD specific E3 ubiquitin protein ligase 1 accelerates diabetic macular edema progression by WNT inhibitory factor 1.

Applications

Unspecified application

Species

Unspecified reactive species

Li-Fang Liang,Jia-Qi Zhao,Yi-Fei Wu,Hui-Jie Chen,Tian Huang,Xiao-He Lu

Cell biology and toxicology 41:7 PubMed39707117

2024

METTL3, m6A modification, and EGR1: interplay affecting myocardial I/R injury outcomes.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Huang,Xun Zhang,Shi-Xiong Wu,Qing Chang,Zhi-Kun Zheng,Jing Xu

Cell death discovery 10:495 PubMed39695152

2024

SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis.

Applications

Unspecified application

Species

Unspecified reactive species

Ganggang Wang,Wenzhi Jin,Lianmei Zhang,Meiyuan Dong,Xin Zhang,Zhijie Zhou,Xiaoliang Wang
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com